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Introduction
Genomic technologies are redefining the understanding of genotype-phenotype relationships. In the early 2000s, array-based genomic technologies enabled gene expression analysis using microarrays, followed by single nucleotide polymorphism (SNP, genetic variation observed in a population) genotyping platforms in mid-2000s, and subsequently by low-cost, high-throughput, massively parallel sequencing platforms in the late 2000s [1] [2] [3] . Genomic sequencing data offer insights into the relationships between the human genomic variations and various molecular and disease phenotypes. Sequencing a biological or clinical sample to characterize genomic, exomic or transcriptomic variations using next-generation sequencing (NGS) technologies helps to identify genomic variations underlying complex diseases. Moreover, approaches such as targeted sequencing of disease-susceptible genomic regions, whole exome sequencing (WES), whole genome sequencing (WGS) and RNA sequencing (RNA-Seq) provide deeper insights into the genetic bases of familial diseases and a better understanding of the biological processes underlying disease phenotypes such as tumors.
Over the past decade, the genetic basis of several complex diseases and clinically relevant quantitative traits were examined using SNP genotyping array-based genome-wide association studies (GWAS). Subsequently, sequencing [4] [5] [6] studies have improved the understanding of the associations between SNPs with clinically relevant traits and human diseases (See http://www. ebi.ac.uk/fgpt/gwas/). SNP arrays have uncovered the more common variations, while sequencing has unravelled much of the rare variants spectrum. The frequency of SNPs in the human genome is approximately 1/300 base pair (bp). SNPs are generally categorized as common variants [in which the minor allele frequency (MAF) ¼ 1-5%] or rare variants (MAF < 1%) according to their population frequencies. Both GWAS and targeted WES and WGS studies have expanded the catalog of genotype-phenotype associations and offered insights into the roles of previously uncharacterized genetic regions in complex diseases [7] [8] [9] [10] [11] [12] .
The rapid increase in the high-quality sequencing data generation using low-cost NGS experimental platforms coupled with speedy bioinformatics algorithms have enhanced the identification of a large number of sequence and structural variants variations (characterized by genomic DNA > 1 kb in size). SNPs are associated with medically relevant phenotypes, as well as diseases [13] [14] [15] and are often observed on a population scale, whereas single nucleotide variations (SNVs) are specific polymorphisms observed in an individual. Recent studies have highlighted the roles of the different types of structural variants (copy number variations, insertions and deletions (indels), inversions, translocations, linking, anchored split mapping, gain/loss) in the genetic bases of several complex diseases [16] [17] [18] [19] . Furthermore, sequencing studies have helped to identify rare personal variants and variants of unknown significance (VUS).
Public repositories of genomic sequencing and variation data have experienced an exponential growth in the past decade. For example Single Nucleotide Polymorphism database (dbSNP) [20] and Ensembl Variation database [21] that archive short genetic variants and structural variants and Database of Genomic Variants [22] that archives a catalog of curated, large-scale genomic structural variants in the human genome are expanding. Since the first GWAS study reported in 2005, so far genetic basis of 1251 traits were discovered. These investigations also led phenotypic annotations for 15 396 SNPs. A large number of clinical-grade genomes, exomes or transcriptomes sequenced for individualized medicine [23] [24] [25] and population-scale sequencing [26] projects such as 1000 genomes [27] , Genome10K (http://www. genome10k.org/) and UK10K (http://www.uk10k.org/) will further add to the size of variant-centric databases in the future. Analysis of the data from the sequencing experiments can be broadly divided into four major tasks: (i) quality assessment of the sequencing reads, (ii) alignment of the sequencing reads with the reference genome, (iii) variant calling and (iv) functional and/ or clinical assessment and prioritization of variants.
The variants identified from the NGS studies present several data interpretation challenges in bioinformatics. The initial data inference is a key filtering step in the identification and prioritization of a subset of variants for functionally important cues and validation studies. The following sections describe a simple framework to classify the available and widely used bioinformatics resources for prediction, annotation and interpretation of coding SNVs. We also discuss 10 different analytical themes that can potentially be investigated from a bioinformatics perspective to obtain a better understanding of coding SNVs.
Landscape of genetic variants
The mutation spectrum of the human genome is complex and has been classified based on diverse criteria such as the mode of inheritance, heterozygosity pattern, impact on chromosome or alleles, impact on protein sequence, structure and function, impact on the population or evolutionary role and penetrance ( Figure 1 ). On the other hand, SNVs may be broadly classified as coding SNVs (functional variations) that perturb the function of a transcript or a protein, or variants may be classified as noncoding SNVs (regulatory variations) that are located in the regulatory elements [promoters, untranslated regions (UTRs), enhancers, human accelerated regions, noncoding RNA genes, transcription factor binding sites (TFBS)] that regulate the expression levels of a transcript or a protein. Regulatory variants may also perturb gene or protein functions via complex cis or trans-activation mechanisms and may, thus, play important roles in influencing the expression and functions of other genes. An example of a functional variant (P33S) in the ribonucleoside-diphosphate reductase subunit M2 B (RRM2B) gene associated with autosomal recessive progressive external ophthalmoplegia is provided in Figure 2 (i) and 2(ii). Another example of a missense variant R363H (rs11556924) in zinc finger, C3HC-type containing 1 (ZC3HC1) gene, is associated with coronary heart disease [28] . P33S in RRM2B is part of a conserved haribonucleotide reductase domain. The variant R363H in ZC3HC1 does not lie within a known functional domain, and thus, the variation is located in an unassigned region of the protein.
The domain architectures of RRM2B and ZC3HC1 along with the location of functional variants are highlighted in Figure 2 (ii). Regulatory variants may influence the expression levels of cis-or trans-acting genes through gene regulation networks. For example, an intergenic variant (rs10811661) in the 9p21 locus, which is harbored near CDKN2A and CDKN2B on chromosome 9, was associated with myocardial infarction [29] and coronary heart disease [9] . A targeted deletion study in mice that investigated the 9p21 region, revealed a regulatory role of the variant in perturbing the expression of two genes (Cdkn2a and Cdkn2b) via a cis-acting mechanism [30] . Another regulatory variant rs342293 (intergenic variant between FLJ36031-PIK3CG), which influences a quantitative trait (mean platelet volume) [31] , perturbed a TFBS of ecotropic viral integration site-1 (EVI1) and influenced the expression levels of PIK3CG [32] . The genomic locations of the regulatory variants rs10811661 and rs342293 that were generated using the Ensembl Genome Browser are highlighted in Figure 2 (iii). Regulatory variants too impact the biological function by altering the level of transcription that may influence protein levels as well. The majority of regulatory variants are not within the protein coding regions, but may indirectly influence gene/protein function via alternative splicing mechanisms [33] . See the recent reviews that summarized the impact of regulatory variation of protein expression and function for a detailed account of regulatory variants [34, 35] .
Prediction, annotation and visualization of coding SNVs
Scientific literature often refers to variants using diverse sets of terms including recommended nomenclature [36] or standard terms from Sequence Ontology (SO) [37] . In this review, we broadly classify genomic variants as 'functional variants' and 'regulatory variants', and we primarily focus on coding SNVs and computational approaches for the prediction, annotation, visualization and interpretation of coding SNVs. The different terms used to define Interpreting functional effects of coding variants | 3 at New York University on February 16, 2016 http://bib.oxfordjournals.org/ variants in the Ensembl Variation resources and dbSNP and their corresponding SO identifiers and descriptions are summarized in Table 1 . The interpretation of variants can be broadly divided into three steps: 'annotation', 'prediction' and 'visualization'.
A given set of variant(s) identified from a sequencing study will be segregated into various classes of genomic variants in the first step in variant annotation (Table 1) . Cross-referencing the variants with reference databases and clinical annotation databases like ClinVar [38] can be used to assess the novelty of genomic variants. Fully automated pipelines can be used to annotate variants based on coordinate specific mapping to genomic regions using proprietary and/or public databases, and various features associated with variant can be derived from such annotation mapping and variant-specific layering approach. For example, a variant can be mapped to a protein-coding region, junction regions or noncoding regions of the genome.
Based on the location of the variant in the protein-coding or noncoding regions, variants (non-synonymous, missense, nonsense or frameshift variants) can be further examined to understand their impact on protein functions. Tools like Combined Annotation-Dependent Depletion (CADD) [39] , SIFT (as tolerated or damaging variants) [40] , PolyPhen2 (as benign, possibly damaging or probably damaging variants) [41] or Condel (metapredictor that combines prediction scores from multiple tools) [42] can be leveraged for predictive assessment of genetic variants. Annotation primarily provides localization of a genetic variant using genome coordinates; prediction aims to hypothesize the probable impact of a particular genetic variant on function or regulation. The combination of annotation and prediction provides an integrated view of genomic variants. Tools such as snpEff or the Ensembl Variant Predictor can be used to predict the impact of a variation in comparison with the reference sequence. The impact of a sequence variant with respect to the evolutionary conservation can also be predicted or derived from GRANTHAM score [43] , genomic evolutionary rate profiling (GERP) score [44] , phylogenetic P-value (PhyloP) score [45] and PhastCons score [46] . The development of substitution matrices in the early 1970s was instrumental in fueling the design and implementation of computational approaches to infer the functional impact of genomic variants [43, 47] . Matrices such as Point Accepted Mutations (PAM1 matrix: substitution probabilities for sequences with a mutation rate of 1/100 amino acids; PAM250 matrix: 250 mutations/ 100 amino acids), BLOCK SUbstitution Matrix (BLOSUM) matrices [48] and sequence search algorithms designed to identify the (CCDC71L)-PIK3CG is located in a TFBS of EVI1 that regulates the expression (repress) of PIK3CG. Genomic regions were visualized using Ensembl Genome Browser v. 67. similarity between any two sequences (pairwise sequence alignment) and the evolutionary relationships between two or more sequences (multiple sequence alignments) have spawned the development of improved heuristic homology search tools [49, 50] . The early 2000s witnessed the development of several predictive methods based on sequence conservation, amino acid substitutions and perturbation of the local structural environment to assess the impact of functional variants in proteins [51] [52] [53] [54] [55] [56] [57] . The ka/ ks ratio (or dN/dS) test, which estimates the ratio of the total number of non-synonymous substitutions per non-synonymous sites (dN) to the total number of synonymous substitutions to synonymous sites (dS), is widely used to quantify the selection pressure on functional genes [52] . Furthermore, bioinformatics tools, databases and statistical methods for the identification, annotation and analysis of SNPs from genotyping and sequencing data have been amply surveyed in literature [58] [59] [60] [61] [62] [63] [64] [65] [66] .
Integrative approaches can provide additional annotations for variants such as the location of the variants within the conserved protein sequence/structure domains (contiguous unit in protein sequence or structure with evidence of functional annotation from experimental or computational function association methods), within known functional sites. Gene Ontology (GO) Together, integrative data analysis platforms (such as TargetMine [70] ) and integrated annotation tools such as ANNOVAR [71] or webservers that can handle Variant Call Format (VCF) [72] files, facilitate the annotations for a large number of sequence variants in a small amount of time.
Adopting a standard set of terms from the SO to define the type of variants would also help in streamlining the interoperability of results from the different prediction tools. A comprehensive list of tools for rapid variant annotation is provided in Table 2 . Table 3 .
Text mining and natural language processing for knowledge aggregation for SNVs Biomedical knowledge about relationships between genes, diseases, phenotypes and genetic variations are scattered across a large number of unstructured literature databases. Application of natural language processing and text-mining, therefore, offers a useful approach for function assignment of coding SNVs. Further text mining of large biomedical literature databases like PubMed and Medline helps to provide clues for further investigations and leads to hypothesis [73] . For example, PhenGen [74] offers links to a variety of literature evidence to support genotype-phenotype connections. Integrated databases like T-HOD database [75] and PolySearch [76] provide textmining tools to derive meaningful biological inferences to interpret coding SNVs.
Emerging challenges in annotation and interpretation of coding SNVs
The growing number of tools for the prediction, annotation and visualization of coding SNVs can address several gaps in the current state of knowledge on variant interpretation. The development of new algorithms for variant interpretation could be considered for several emerging themes of the protein sequence-structure-function paradigm. Several tools [See Tables  4, 5 and 6] are currently available to assess sequence and structure-based features; yet, a reliable interpretation on how a genomic variant could perturb a protein or a protein network is often a challenging task.
VUS (also known as incidental variations or secondary variations) are a class of variants hitherto unknown in known disease genes, but the influence of these variants on the disease phenotype is largely unknown. Pilot data from 1000 Genomes project on exon capture sequencing of 1092 individuals selected from 14 populations across Europe, East Asia, sub-Saharan Africa and the Americas reported an observed frequency of 2500 non-synonymous variants at conserved positions; 20-40 variants identified as damaging; 24 at conserved sites and about 150 loss-of-function (LOF) variants that includes stop-gains, frameshift insertions and deletions (indels) in a coding sequence and disruptions to essential splice sites. Emerging evidence suggests that rare variants may have a higher collective impact on disease incidence rate than common variants, and considering the allele frequency as a metric to assess the clinical impact of the variant may help to assess the clinical impact of VUS. Majority of the variants identified in individuals in 1000 Genomes project are common with >5% of MAF or low frequency (MAF: 0.5-5%) than rare variants (MAF: <0.5%). Rare variant frequencies estimated as 130-400 non-synonymous variants per individual that includes 10-20 LOF variants, 2-5 damaging mutations, and 1-2 variants identified from cancer genome sequencing projects [77] [78] [79] . As an ever-increasing number of VUS are being characterized, their annotation and interpretation is becoming more challenging. With the advent of WGS and WES in clinical settings, the repertoire of VUS associated with complex, chronic and rare diseases is rapidly expanding. We surveyed the Human polymorphisms and disease mutations index (humsavar.txt) to gather unclassified variants reported in UniProtKB, a curated database of functional information on proteins. The current release (2014_05) of the humsavar lists 6564 variants as 'Unclassified variants'; these variants were mapped to 1910 protein coding genes. A manually curated annotation of the variants and disease ontology-based disease term-gene enrichment analyses indicated that the genes were largely from cancer patients (322 genes tested; P < 0.05). We noted that 497 genes encoded polymorphism, disease and unclassified variants, suggesting that VUS-labeled variants may directly influence the genes that are relevant to human diseases and clinically relevant phenotypes. A proportional Venn diagram of genes mapped to variants labeled as 'Polymorphism', 'Disease' and 'Unclassified' is illustrated in Figure 3 . The top 10 disease ontology terms enriched among the genes within the three classes of variants are summarized in Table 2 . We observed that certain diseases were represented by genes that share multiple classes of variants, thereby suggesting that unclassified variants may play a key role in certain clinical conditions such as cancers, chronic diseases (diabetes, atherosclerosis, hypertension and kidney disease), neurodegenerative disease (Alzheimer's disease) and infection (P < 0.05; Bonferroni corrected). Annotating functional coding SNVs including VUS validated using an orthogonal method also requires detailed sequence, structure and interaction-based analyses. In this context, we discuss some of the predictive features and analytical approaches that once incorporated in coding variant annotation algorithms, may potentially enhance the interpretation of the functional variants on a proteome-wide scale.
Sequence and structural properties perturbed by coding SNVs
A protein performs its defined function after attaining a specific tertiary or quaternary structure [80, 81] . This is often mediated by cross-links of inter-chain and intra-chain amino-acid residue interactions within a protein. These interactions (hydrogen bond, disulphide bonds, salt bridges, ionic interactions, electrostatic interactions, hydrophobic interactions, etc.) stabilize the fold of individual protein chains and the overall quaternary assembly. Individual amino acids within a protein are under the influence of the varied elements of the sequence-structurefunction paradigm that modulate their biochemical role [82] . Primarily, a residue may be located within an evolutionarily conserved compact globular domain [83] or in an unassigned region with no known protein domain association [84] . A residue can be a part of a motif which can be functional [85] , that of a linear motif [86] , propeptide [87] , signaling peptide [88] or a part of structural [89] and spatially interacting sites, which participate in higher order interactions [90] , catalytic sites [91] , ligand binding sites [92] and allosteric sites [93] associated with extensive inter-chain and intra-chain interactions [90] based on the oligomeric property of the proteins. Amino acids can also be part of specific sub-cellular localization signals that direct the proteins to specific locations in the cell [94] . The lengths of the proteins [62] , sequential localization (N-terminal, C-terminal or other region of protein sequence) and the location of a coding SNV with respect to the surface-interior or interface of the protein structure-could influence disease manifestation [95] . Table 4) that functional variants may impact the overall structural conformation and function of proteins (ligand binding, substrate specificity, protein-protein interaction, transcription factor-target binding, etc.). Residue-specific interactions can play a key role in such variations. Sequence-based investigations will further help to identify linear sequence motifs that confer diversity in the splice variants [6] , but the identification and analysis of the impact of point mutations on spatially distributed structural motifs may require structural data [55] . However, the limited availability of structural data compared with sequence data may pose additional challenges for incorporating structural analysis of the functional variants [96] . Moreover, additional challenges arise owing to the dynamic protein conformations and allosteric or other long-distance effects (including higher order interactions) of few mutations on the activity of the protein.
UniProtKB provides extensive information about residue properties and curated information about globular domains (via annotations derived from Pfam, SMART or InterPro), posttranslational modifications (PTMs) and several bioinformatics tools and webservers are available to investigate residue properties and structural properties. (See Table 5 for a list of tools to predict various sequence features. See URL http://bio informatics.ca /links_directory/category/protein for list of tools available for different protein-centric analyses.)
Occasionally, multiple sequence or structural features can be annotated onto a single variant: for example, a residue could be part of a functional motif and/or a structural motif, and coding SNVs may perturb either or both features. Quantifying multiple features perturbed by variants using an objective-scoring schema will help to capture the entire set of features perturbed by a functional variant. Comparative analysis of the sequence and structural features of the wild type and the variant sequences will also enhance the understanding of the impact of multiple coding variants within a protein.
Gain and loss of PTMs owing to SNVs
Amino acids in a mature peptide chain are targets of varied PTM [97] events. PTMs include phosphorylation, methylation, acetylation, amidation, hydroxylation, sulfation, lipidation, glycosylation and palmitoylation [98] . Several studies have now compiled and assessed the impact of phosphorylation in cancer [97] and have reported mutational landscapes of various PTM events including gain or loss of particular PTMs owing to SNVs (for example, gain of glycosylation [99] , gain and loss of phosphorylation in cancer [100] ). Pan-cancer [101] and proteome wide studies [102] have also assessed the impact of variety of PTMs. Several tools and databases are currently available to assess impact of individual PTMs owing to SNVs [refs?]. However, tools that can provide complete in silico profiling of mutations will help the researchers to identify PTM-relevant mutations and use the information to assess therapeutic stratifications.
Coding SNVs in unassigned regions of proteins
An unassigned region refers to the segments in proteins with no known functional domain assignments [84] . Human proteins have a variable degree of unassigned regions, and small-unassigned regions are often defined as the linker regions between two domains (Figure 2i) . We surveyed the human proteome using Pfam-based domain annotations to understand the unassigned regions in the human proteome. We computed assigned and unassigned regions (in percentage) for 20 242 protein sequences from the SwissProt database (reviewed sequences). Pfam-A-based domain assignments were retrieved for 20 137 sequences. A subset of 105 proteins was excluded from the analysis owing to overlapping domain assignments. Of the 20 137 sequences that were analyzed ( Figure 4A ), one protein (haloacid dehalogenase-like hydrolase domain-containing protein 2) was assigned with a conserved domain over its entire length, 3234 sequences were completely unassigned and the rest of the proteins had varying segments of unassigned regions (mean: 53.87%; SD:630.94%). Current approaches in variant annotation and interpretation are primarily focused on highly conserved globular domains. Given that domains are presently assigned to only 50% of the human proteome, analytical methods such as Prediction of Unassigned Regions (PURE) that use intermediate sequence search techniques for domain assignments [103] or similar approaches that use sensitive sequence search protocols 
Impact of coding SNVs in low-complexity regions
Low-complexity regions (LCRs) in the protein universe refer to a stretch of amino acids with low Shannon entropy (leucine-rich domains or poly-alanine tracts). Unlike linear motifs, which have a specific function and sequence signature, the individual functions of LCRs are poorly characterized. LCRs do not adopt a definite secondary structure but may exist as solvent-exposed amino acids in the coiled or disordered regions in proteins. LCRs are observed in functionally diverse proteins and in both eukaryotes and prokaryotes. The predominant functions of LCRs include promoting mRNA stability and mediating a diverse set of protein-protein interactions [104] . We scanned the reference human proteome (reviewed subset of 20 237 sequences) using PFILT [105] and observed that 14.32% (n ¼ 2899) protein sequences have LCRs with a median length of 16 amino acids ( Figure 4B) . A recent study showed that a functional variant localized to an LCR in Nance-Horan Syndrome (NHS) gene was associated with clinical features of NHS including cardiac anomaly [106] . In the absence of direct functional information to interpret the impact of functional variants, scanning protein sequences with an LCR prediction tool like PFILT is highly recommended to investigate the probable gain or loss of LCRs owing to the functional variations.
Coding SNVs and intrinsically disordered regions in proteins
Proteins are believed to be functional when the structure attains its definite globular fold [107] . Recent studies, however, suggest that proteins may perform their functions even when not in a fully folded state. Such proteins or regions within proteins that exist in a stable conformation without attaining a definite structural conformation are generally referred to as intrinsically disordered proteins (IDPs) or proteins with intrinsically disordered regions (IDRs) or simply disordered proteins [108, 109] . Disprot is a database that catalogs a curated list of disordered proteins that includes 248 experimentally validated human proteins with disordered regions (http://www.disprot.org/actionsearch. php?keyword¼human&criterion¼organism). Prediction models suggest that 30-40% of human proteins are considered to be IDPs or have IDRs and approximately 25% of eukaryotic proteins are predicted to be fully disordered [108, 109] . Regions of the intrinsically disordered segments in proteins have been found to be functionally important ( Figure 5 ). Disordered regions mediate various functional roles including protein binding and protein-protein interactions. Previous studies have shown that IDPs can attain a definite structure on binding to their interacting partner and may thus exist in an intermediate stage of disordered (unfolded) to ordered (folded) stage [110, 111] . Irrespective of the structural plasticity, recent 
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at New York University on February 16, 2016 http://bib.oxfordjournals.org/ Downloaded from studies have shown the presence of evolutionarily conserved functional motifs within IDPs [112, 113] . Recently, the influence of disease mutations in the disordered regions was extensively surveyed, and the crucial roles of disorder-promoting amino acids in imparting variations in the protein structures were proposed [114, 115] . Disorder-promoting amino acids are a potential cause of variations in protein structures and structural models. Disorder-to-order transitions are enriched among disease mutations compared with neutral polymorphisms [116] . Currently, protein modeling or variant effect prediction algorithms do not take the intrinsic disorder characteristics of a protein into consideration. Integrating tools such as Disopred [117] for disorder region prediction into the variant annotation pipelines will improve our understanding of the impact of coding SNVs in the disordered regions of a protein.
Influence of coding SNVs on protein misfolding, domain swapping, aggregation, macromolecular crowding and degradation
Diseases have multiple environmental, as well as genetic, causes and structural biology is an active area of research to understand how changes in individual protein structures or protein complexes may play a key role in disease manifestations. Understanding the structural bases of human diseases would help to identify better targets and design better ligands for more effective therapeutic interventions.
Protein misfolding and aggregation
Protein folding pathways play a crucial role in mediating cellular homeostasis. Defective folding of a protein product is the mechanistic basis of several disease phenotypes like Alzheimer's disease and Parkinson's disease [118] . When nonsynonymous mutations lead to the production of misfolded proteins with aberrant function, several gate-keeping pathways act on such misfolded proteins to clear them from the cellular environment [119] . Misfolded proteins targeted for ubiquitylation may also lead to protein aggregation. Protein aggregation [120] [121] [122] [123] is defined as a molecular phenomenon where a protein is not cleared from the cellular environment by the normal pathways ( Figure 6A ). This leads to the aggregation of proteins in the cellular environment, which in turn leads to cellular toxicity and is considered to be the mechanistic basis of various human diseases such as prion diseases [123, 124] .
Domain swapping
3D domain swapping ( Figure 6B ) is a phenomenon observed in a subset of proteins where intermolecular interactions are replaced by intramolecular interactions [125, 126] . Domain swapping is also recognized as a mechanism for forming protein aggregates via open-ended mode. Domain swapping is observed in a variety of therapeutically important proteins and is considered to be the mechanism mediating deposition diseases such as neurodegenerative diseases and Alzheimer's disease that are caused by conformational perturbations [127, 128] . Missense mutations in the human phenylalanine hydroxylase have been shown to infleunce aggregation and degradation properties [129] . Functional mutations are also considered to be a causative factor for proteins to adopt swapped conformation from monomers to higher oligomers [130] [131] [132] . A recent study [128] that surveyed a subset of human proteins involved in 3D domain swapping suggested that swapping is not only confined to conformational diseases; it is also associated with several key biological pathways and also plays a role in mediating diverse diseases in humans. Another study [133] that investigated the structural properties of proteins involved in 3D domain swapping suggested that 10% of protein folds and 5% of protein families include domain-swapped structures.
Macromolecular crowding
Proteins interact with a variety of small molecules and other macromolecules to perform a specific functional task. The quaternary assembly of a protein is influenced by the important, yet understudied, phenomenon of macromolecular crowding (117, 118) . Protein function is driven by interactions mediated by inter-and intra-chain amino acids, and mutations in the surface amino acids may affect macromolecular homeostasis. Mutagenesis studies have shown the impact of functional mutations on protein-protein interfaces (119), oligomerization (120) and stability (121) . Mutations that influence the intra-chain interactions may influence the crowding effect in the cellular environment. Probing the impact of functional mutations on such effects using theoretical models and molecular dynamic simulation studies is likely to enhance the understanding of the relationship between coding SNVs and macromolecular crowding. A list of selected tools and databases available for the prediction of misfolding, protein aggregation and domain swapping is summarized in Table 5 .
Protein degradation
Targeted biochemical studies have revealed that the protein degradation pathway plays an important role in the clearance of the mutated proteins to reduce cellular toxicity. For example, mutant Cu, Zn-superoxide dismutase associated with amyotrophic lateral sclerosis was cleared by macroautophagy pathway that includes proteasomal cleavage; phenylalanine hydroxylase (109) and NAD(P)H: quinone oxidoreductase 1 (156) (a) ( b) Figure 6 . Schematic representation of the impact of functional mutation on protein misfolding, folding, aggregation, domain swapping, macromolecular crowding and protein degradation pathways. Structure of misfolded rat CD2 structure (PDB ID: 1A6P) and normal CD2 (PDB ID: 1HNG) is used for representing misfolded and folded structures. Functional variant is represented using red asterisk.
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at New York University on February 16, 2016 http://bib.oxfordjournals.org/ were also cleared by similar mechanisms. Functional variants play a crucial role in aggregation and protein degration pathways [134, 135] . Computational approaches that can predict the degradation properties of mutated proteins using sequence or structural information will be useful for rapid characterization of functionally active proteins. Integrated models that combine folding, misfolding, aggregation, 3D domain swapping, macromolecular crowding and degradation pathways ( Figure 6 ) in a systems biology approach are likely to provide additional insights into the regulation of these important mechanisms and the role of coding SNVs in mediating such mechanisms.
Coding SNVs and metamorphic proteins
The molecular paradigm of sequence-structure-function suggests that a diverse set of sequences could attain a similar structural fold that may lead to a functional convergence. While this is generally true for the protein universe, occasionally deviations are observed. Metamorphic proteins refer to a relatively new class of proteins in which a given sequence has been shown to attain different folded conformations under native conditions while performing distinct functions [136] [137] [138] . Metamorphic proteins such as human chemokine lymphotactin have been shown to influence evolutionary transitions of structure and coding SNVs, which could play an important role in switching between two or more folds and functions for a single sequence [139] . Computational approaches to catalog and predict the metamorphic properties and the impact of coding SNVs on metamorphic proteins would help us understand how mutations drive functional plasticity at the proteome level.
Impact of coding SNVs on the transcriptomic diversity
Dynamic features of the human proteome are driven by transcript diversity, and the average number of characterized transcripts per gene is rapidly expanding. The recent adoption of RNA-Seq as a tool for expression profiling has led to the characterization of a large number of novel transcripts including fusion transcripts [140] . Several novel tissue-specific or cell-type-specific transcripts were reported from RNA-Seq experiments. The cellular compartment-based functional roles of such transcripts are determined by alternative splicing events [141] . RNA editing is a phenomenon where a pre-mRNA molecule is altered through a chemical change in the base makeup, thereby adding to the diversity of the transcriptome. RNA editing events occur via two distinct mechanisms of substitution editing and insertion/deletion editing, leading to functional diversity. Fusion transcripts [142] and RNA editing events are also associated with various diseases including prostate cancer and amyotrophic lateral sclerosis [143] . Computational approaches are available for the identification of fusion transcripts [144] and RNA editing events [145] [146] [147] from sequencing data. Understanding the precise roles and the impact of variants on such a diverse set of transcripts using computational approaches is a challenging task. Ascribing the functional role and assessing the impact of coding SNVs for mediating novel and fusion transcripts using bioinformatics approaches is an emerging problem and being addressed in recent studies [148] . Recently, we designed an integrated method to simultaneous analyses of genome and transcriptome from RNA-seq data. The eSNV-Detect method can precisely capture genetic variation (genotypes) from RNA-seq data and helps to design costeffective and sustainable experimental strategies [149] . Analytic and interpretation strategies that rely on multiple data-types would provide greater confidence for variant calling, annotation and interpretation and thus actionability for clinical interventions.
Functional impact of synonymous variations
Synonymous mutations are defined as mutations that result in a variation at the DNA level that code for the same amino acid in the protein level owing to codon degeneracy. Synonymous variants may either be coding or noncoding and the functional roles of such variants are emerging. A recent study [150] suggests that introns are involved in functional mechanisms, and introns with positional conservation across eukaryotic lineage are classified as functional introns. A comparative analysis of synonymous and non-synonymous variants associated with complex diseases has shown similar likelihood and effect size with disease association [151] . Synonymous mutations may also influence the introns regulating gene expression [152] . A recent report also suggests that the coding exons function as tissue-specific enhancers and synonymous variations in such enhancer sites may influence the expression level of certain genes [153] . Synonymous variants could influence the expression of intronic noncoding RNAs [154] , perturb the transient protein-DNA [155, 156] and protein-RNA interactions in the cell. Such perturbations can lead to diseases such as cancer, neurological disorders and cardiac disease [157] . Developing bioinformatics approaches to explore the putative impact of synonymous mutations on different layers of the coding and noncoding genome and their relationships will be an important aspect in the detailed interpretation of the genomic variants. The detailed structural exploration of protein-DNA [158] and protein-RNA interactions [159] will help to precisely map the mechanistic bases of the loss or gain of interactions owing to synonymous variations.
Impact of coding SNVs on the interactome of a protein
The individual interactome of proteins varies to a great extent [160] . Proteins often interact with nucleotides (protein-DNA or protein-RNA interactions), proteins (protein complexes, obligate or non-obligate) [161] and protein-protein interactions (transient or permanent) [107] ) and small molecules (molecular reactions, enzymatic reactions, metabolic pathways) [162, 163] . Coding SNVs play an important role in mediating such interactions. An interactome of a protein can be defined using information gathered from high-throughput experiments that systematically identify interactants of proteins. Public protein-protein databases like BioGRID [164] and STRING [165] provide large data sets for deriving a protein interactome. Network-level investigations to understand the category of interactors that are perturbed owing to coding SNVs will help delineate the impact of such mutations on the protein interactomes. Using network measures (centrality, degree, stress, betweenness, closeness, cliques, radiality, transitivity, reciprocity, assortativity, structural equivalence, network heterogeneity, network density, clustering coefficients, neighborhood connectivity, shared neighbors, network topology, etc.) as quantitative parameters in variant annotation pipelines will help the researchers gain better insights into the impact of coding SNVs on the protein interactome. Biologically relevant network properties such as network modularity [166] , network fragility [166] and lethality [166] can also be derived from an interactome. Incorporating a comparative network analysis framework that compares wild-type and variant interactomes will help quantify the impact of coding SNVs on a network scale. Methods such as VCF2Networks employ genotype networks (i.e. all genotypes associated with a single phenotype) to understand the relationships between the genotype space and clinical or biological phenotypes [167] . Table 7 summarizes the available tools to investigate gene lists and to derive global functional trends and network properties.
Pathway-level impact of coding SNVs
Multiple functional genomics studies have investigated the perturbations of pathways as a result of mutations in diseases such as adenocarcinoma (MAPK signaling, p53 signaling, Wnt signaling, cell cycle and mammalian target of rapamycin pathways) [168] , childhood acute lymphoblastic leukemia (RAS pathway) [169] , colorectal carcinoma (WNT signaling pathway) [170] , etc. Several SNP-centric approaches for pathway-level inference have been designed for the interpretation of SNPs identified from GWA studies or differentially expressed genes from geneexpression studies [171] [172] [173] [174] [175] . Coding SNVs may also influence the cross talk between various signaling pathways. Current variant interpretation algorithms strive to identify pathways associated with genes harboring coding SNVs; yet, a detailed understanding of the impact of variants on biological pathways and pathway cross talks [176] is often lacking. Incorporating analytical routines to quantify the effect of functional mutations on pathways and pathway cross talk will be useful in interpreting functional variants from a biological perspective.
A classification schema for annotating coding SNVs
Identifying the entire spectrum of molecular perturbations owing to coding variations at the level of sequence, structure, interaction and function of proteins is considered the basis of variant interpretation. Multiple automated prediction tools that can assess the functional effect of mutations are currently available [See Table 6 ]. Several variant annotation tools focus on the task of predicting the type or effect of mutations, provide extended annotations from precomputed databases or lookup tables and map a coding variant to its corresponding gene, protein, functional domain or signaling pathway. These approaches have several limitations because additional layers of protein-centric information that can be derived from the prediction or computation of sequence-based features with coding variants are lacking. To deal with this challenge and to design broad-spectrum tools for deep variant interpretation, we 
Level 1: Primary annotation of coding SNVs
Tools that use position information from VCF files to derive the type of mutation (synonymous or non-synonymous), the location of the corresponding gene and its mapping onto several annotation resources using positional data may be viewed as 'primary annotations'. See Table 2 for a list of tools that use minimum input data to gather a diverse set of annotations using database lookup tables and identifier mapping. Comparative analysis of wild-type and variant sequences can be performed and quantified using the total number of gains or losses in the sequence features. Based on the availability of the structural data, a given variant can be modeled in a protein structure using in-silico mutagenesis experiments. In the absence of experimental protein structural data, a protein structure model can be obtained from the homology model database or a new model can be built using homology modeling approaches. Once the wild type and mutant type structures are obtained, the impact of variation can be rapidly computed using structural feature analyses or using computationally expensive molecular dynamics simulations. Table 5 summarizes key sequence and structure feature prediction tools.
Level 3: Tertiary annotation of coding SNVs:-Impact of coding SNVs on multiple genes, pathways and interactome
The global impact of multiple coding variants on a genome or exome can be assessed using a combination of both knowledgebased enrichment or depletion analysis and network or interactome analyses. Functional profiling using GO terms have been used as an effective approach for characterizing collective functional characteristics of a perturbed set of genes [177, 178] . Gene-list-based analyses can provide biologically relevant information about the variants. Enrichment analysis is not just confined to a priori defined gene sets or GO annotations; enrichment can be performed using several types of annotations and could provide insights into the probable functional associations of genes with coding variants. Enrichment analysis using protein annotations would help to identify functionally significant protein domains, protein classes, families (membrane proteins or kinases, etc.), protein superfamilies (angiotensin receptors or G-protein coupled receptors) or protein folds (Rossman fold, beta-propeller) associated with proteins Figure 7 . Three-level schema for annotation of functional variants.
harboring coding variants. Furthermore, it is possible to identify enriched molecular events mediated by genes, enriched TFBS in the upstream of genes and biological pathways mediated by the genes using annotations from Reactome, UCSC and KEGG repositories. Disease ontology can be used to find known genedisease associations. Following the knowledge-based analysis, a network-level analysis of genes harboring coding SNVs can be performed using publicly available network analysis tools such as Cytoscape and Gephi.
Future directions
The rapidly increasing availability of sequence, structure, functional and interaction information offers an attractive means to obtain a detailed characterization of coding variants. However, the use of large data sets to systematically explore the functional variants is currently limited owing to the gaps in the available sequence-structure-function interaction data. Sequence data are available for the entire human proteome, but the availability of protein structural data, experimentally verified functional associations and biomolecular interaction data is limited. The availability of structural data of homologous protein structures is a prerequisite for structural investigations of functional variants and its impact on the structural environment. Availability of high-quality interaction data will also help analyze the cellular networks modulated by proteins harboring coding variants. The expansion of structural data sets using structural genomics [179] , homology modeling [180] and the application of computational approaches such as genomics-aided structure prediction [181] is likely to lower the increasing chasm between sequence, structure, function and interaction data and may help to ascertain the impact of variants at the biomolecular level [163, 182, 183] . Improving the annotation databases using high-quality, curated data and integration with cloud-based or stand-alone pipelines [184] [185] [186] [187] [188] [189] can also help facilitate such efforts. The current version of the Bioinformatics Link Directory enlists >900 bioinformatics tools that are capable of processing different types of protein data (sequence, structure, interaction, quantification and annotation). Unifying multiple resources and enabling programmatic access via application program interfaces and web services for rapid integration will significantly enhance the efficacy of variant annotation pipelines. The development of novel statistical methods that can quantify various residuespecific properties would enable a comparative analysis of wildtype and variant sequences and can thereby help to facilitate the identification and prioritization of functional mutations. The inclusion of a diverse set of sequence, structure and network features into a graphically depicted database and an assessment of the impact of various data types (sequence, structure, function and interaction) using probabilistic or machine learning models would also help automate variant annotation interpretation.
From a sequence perspective, understanding the precise functional role of LCRs, unassigned regions and disordered regions as well as the relationship between these features and coding SNVs is a key step in variant annotation and interpretation. Identifying deviations in protein structural space that are likely to lead to misfolding, domain swapping, aggregation, degradation or deviations that are metamorphic in nature owing to the impact of coding SNVs is an emerging challenge. Several algorithms are available to predict sequence or structural domains, assign distantly related domains to unassigned regions, functional motifs, structural motifs and structural features, protein disorder and aggregation propensities. However, algorithms and tools to predict 3D domain swapping or to analyze metamorphic properties, degradation pathways and the network-level impact of coding SNVs are less abundant. This may be attributed to the fact that these concepts are continually evolving in the protein universe and concerted efforts are needed to understand the impact of coding variants of such unique features from both experimental and computational biologists alike.
This review summarizes the major bioinformatics challenges involved in gaining a deeper understanding of coding SNVs. Coding SNVs may impart a molecular or disease phenotype by interacting with noncoding, regulatory parts of the genome and the structural variants may provide an important contribution to this phenomenon. Analyzing functional and regulatory variants in a single analytical framework may further enhance the interpretation of the genomic variants.
Conclusions
A rapid decline in sequencing costs using NGS technologies has led to an exponential increase in the frequency of the sequencing projects over the past decade. A large number of personal genomes and exomes, clinical samples and cancer genomes are being sequenced as part of large-scale collaborative projects. The identification of a plethora of sequence variants associated with diverse molecular and disease phenotypes. Scalable computational approaches that integrate annotations using sequence, structure, functional and interaction data are necessary for the rapid interpretation of coding SNVs. We have discussed the bioinformatics resources available for the prediction, annotation and visualization of coding SNVs, summarized the major bioinformatics challenges into 10 different themes for a deeper interpretation of coding SNVs and recommended a three-level schema to assess the phenotypic impact of functional variations on individual protein sequences, structures, different functional categories, biological pathways and interactomes. We envisage that addressing the key challenges discussed in this review and adopting a comprehensive annotation schema for variant annotation could improve genomic reports that are generated as part of genomic medicine investigations and experimental studies to better understand the variations implicated in rare, common and complex disease manifestations.
Key Points
• Interpretations of variants identified from next-generation sequencing pose several challenges.
• Systems-level experimental investigation of the functional variants is expensive and time-consuming; efficient computational techniques are required to identify the impact of functional variants.
• We recommended an integrated approach that combines multiple data types and tools for the prediction, annotation and visualization of functional variants and we have proposed a systematic approach for functional variant annotation and interpretation.
• Significant challenges that need to be negotiated during the interpretation of coding single nucleotide variants are presented with the help of various examples.
• A three-level annotation approach that combines the information at the level of an individual variant, multiple variants in a single protein and global trends of multiple genes harboring multiple variants is proposed for an effective interpretation of coding single nucleotide variants. 
